ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Psychotherapy for older adults with depression: a narrative review.
Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Perioperative Depression and Anxiety Care in Older Patients: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Neuropsychiatric illness in the later years of life: summary and synthesis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Review
- Quality, reliability, and transparency of late-life depression videos on Chinese social media: a cross-sectional study of Douyin, Rednotes, and BiliBili.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The purpose of this narrative review was to examine the efficacy and effectiveness of psychotherapy for older adults with depressive disorders or clinically significant depressive symptoms; describe extensions of psychotherapy across populations, settings, providers, and modalities; review mechanisms and predictors of treatment response; and consider future directions. Numerous systematic reviews and meta-analyses demonstrate that psychotherapy benefits many depressed older adults, with the strongest evidence for a variety of cognitive-behavioral therapy (CBT) approaches, including problem-solving therapy (PST) and behavioral activation (BA), and consistent evidence for interpersonal, reminiscence, and life review therapies as well. Great advances have been made extending these interventions, particularly CBT-based interventions, such as adaptations for older adults with psychiatric, physical, or cognitive comorbidities; in primary care, aging services, and residential settings; and low-intensity, often technology-based interventions. Several neurobiological, psychological, behavioral, social, and treatment-related mechanisms and predictors of psychotherapy response have been identified, which may explain heterogeneity of treatment effects and may lead towards more personalized, tailored interventions to achieve better outcomes for more older adults. More research is needed in all areas, including expanding from traditional psychotherapy models to novel technology-based, neuroscience-informed interventions, and implementation research to continue expanding the reach, feasibility, and acceptability of evidence-based psychotherapy.
Identifiers
41535633What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.